Unknown

Dataset Information

0

A case report of a novel 22?bp duplication within exon 1 of the UGT1A1 in a Sudanese infant with Crigler-Najjar syndrome type I.

ABSTRACT: BACKGROUND:Crigler Najjar type 1 is a rare autosomal recessive condition caused by the absence of UDPGT enzyme due to mutations in the UGT1A1 gene. This enzyme is responsible for elimination of unconjugated bilirubin from the body by glucuronidation. Affected individuals are at risk for kernicterus and require lifelong phototherapy. Liver transplant is the only definitive treatment. CASE PRESENTATION:Here we report a case of a 6?month old Sudanese female infant with CN1 whose molecular analysis revealed a novel homozygous 22 base pair duplication (c.55_76dup) in the coding exon 1 of the UGT1A1 gene. This 22?bp duplication causes a frame shift leading to a premature stop codon. She underwent a successful liver transplant at 7?months of age and is doing well at 1 year follow-up. CONCLUSION:This study shows that molecular diagnosis helps in precise diagnosis of CN1 and in prognosis, prompt medical intervention and appropriate therapy. This particular 22?bp duplication within the coding region of UGT1A1 can be a founder mutation in the Sudanese population.

SUBMITTER: Valmiki S 

PROVIDER: S-EPMC7060512 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

A case report of a novel 22 bp duplication within exon 1 of the UGT1A1 in a Sudanese infant with Crigler-Najjar syndrome type I.

Valmiki Sailaja S   Mandapati Kiran Kumar KK   Miriyala Leela Krishna Vamsee LKV   Kelgeri Chayarani Chandrashekhar CC   Rela Mohamed M   Shanmugam Naresh P NP   Vegulada Durga Rao DR  

BMC gastroenterology 20200306 1

<h4>Background</h4>Crigler Najjar type 1 is a rare autosomal recessive condition caused by the absence of UDPGT enzyme due to mutations in the UGT1A1 gene. This enzyme is responsible for elimination of unconjugated bilirubin from the body by glucuronidation. Affected individuals are at risk for kernicterus and require lifelong phototherapy. Liver transplant is the only definitive treatment.<h4>Case presentation</h4>Here we report a case of a 6 month old Sudanese female infant with CN1 whose mole  ...[more]

Similar Datasets

Unknown Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome.
| S-EPMC6169020 | biostudies-literature
Unknown Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.
| S-EPMC4439166 | biostudies-literature
Unknown Molecular Analysis of the UGT1A1 Gene in Korean Patients with Crigler-Najjar Syndrome Type II.
| S-EPMC3990781 | biostudies-literature
Unknown UGT1A1 gene mutation due to Crigler-Najjar syndrome in Iranian patients: identification of a novel mutation.
| S-EPMC3826477 | biostudies-literature
Unknown A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome.
| S-EPMC5052023 | biostudies-literature
Unknown Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice.
| S-EPMC6972964 | biostudies-literature
Unknown Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1.
| S-EPMC6391595 | biostudies-literature
Unknown Recommendations for pregnancies in patients with crigler-najjar syndrome.
| S-EPMC3575037 | biostudies-literature
Unknown Two unrelated patients with rare Crigler-Najjar syndrome type I: two novel mutations and a patient with loss of heterozygosity of UGT1A1 gene.
| S-EPMC4076604 | biostudies-literature
Unknown Update on a previously reported missense mutation: The c.1160 C>A mutation in the UGT1A1 gene result in Crigler-Najjar syndrome type 1.
| S-EPMC8606201 | biostudies-literature